Using Capillary Lactate Levels to Predict Outcomes in Severe Trauma Patients Before Hospital Arrival

What this Trial Is About

Researchers are studying the use of capillary lactatemia to assess the severity of potentially severe polytrauma patients before they reach the hospital. Current tools like vital signs and shock scores have limitations and can be subjective. Capillary lactatemia is a simple and quick test that could help predict poor outcomes in trauma patients, similar to venous lactatemia, but has not yet been studied in this context. The study involves collecting capillary blood samples during the transfer of trauma patients to emergency facilities. These samples are analyzed to measure lactate levels at inclusion and again six hours later. The goal is to see if capillary lactate levels can improve the prediction of severe outcomes and help guide better patient management in the pre-hospital setting. Participants will be trauma patients aged 18 or older, who have suffered serious injuries like road accidents or falls over two meters and require emergency medical assistance. The study measures lactate values at two time points and monitors patient outcomes. Consent is obtained from the patient or a relative, and pregnant women can participate safely. The study runs until December 2027 and includes continuous assessment during hospital transfer and emergency care.

Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients